David Jon Colliflower, PA-C

David Colliflower practices at Sonoma Valley Hospital in Sonoma, California, part of Sonoma Valley Hospital.

David Colliflower's NPI, 1891900346, was assigned on May 10, 2007. David Colliflower holds California license 15993.

David Colliflower's primary practice is Sonoma Valley Hospital, at 347 Andrieux St, Sonoma, CA 95476 in Sonoma County. The practice phone is (707) 935-5000.

David Colliflower's primary practice is Sonoma Valley Hospital in Sonoma, California, part of Sonoma Valley Hospital. The medical group on file is UCSF Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where David Colliflower practices. Vendor and product names are available with a free account.

Surgical is David Colliflower's primary specialty in the NPI Registry, under taxonomy code 363AS0400X. David Colliflower is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Dmand AI has David Colliflower's licenses on file in 2 states: California and Washington.

Dmand AI lists ankle or foot injury, arthritis, bursitis, joint pain, knee injury, lower back pain, minor injury to a limb and rotator cuff injury among the conditions David Colliflower treats.

CMS data shows 7,792 Medicare services from David Colliflower across 9 procedure codes in 2024, for 275 Medicare patients. Medicare paid $55,736 for them. Every service was in an office.

CMS counts 275 Medicare patients who saw David Colliflower in 2024. The largest group is 75 to 84, with 109 patients. 75% of them have arthritis, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.24, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts David Colliflower's median patient age at 71, with 57% women.

In 2024, David Colliflower wrote 208 Medicare Part D claims for 77 patients. 99% of them were for generic drugs. CMS names the drug for 148 of them, across 6 drugs with 11 or more claims each, at $669 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for David Colliflower for performance year 2024. David Colliflower accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to David Colliflower from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Heron Therapeutics, Inc. paid the most, $18.

David Colliflower is a member of AAPA.